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Abstract
Background: Dengue viruses are a major cause of morbidity in tropical and subtropical regions of the world. Inapparent
dengue is an important component of the overall burden of dengue infection. It provides a source of infection for mosquito
transmission during the course of an epidemic, yet by definition is undetected by health care providers. Previous studies of
inapparent or subclinical infection have reported varying ratios of symptomatic to inapparent dengue infection.
Methodology/Principal Findings: In a prospective study of school children in Northern Thailand, we describe the spatial
and temporal variation of the symptomatic to inapparent (S:I) dengue illness ratio. Our findings indicate that there is a wide
fluctuation in this ratio between and among schools in a given year and within schools over several dengue seasons. The
most important determinants of this S:I ratio for a given school were the incidence of dengue infection in a given year and
the incidence of infection in the preceding year. We found no association between the S:I ratio and age in our population.
Conclusions/Significance: Our findings point to an important aspect of virus-host interactions at either a population or
individual level possibly due to an effect of heterotypic cross-reactive immunity to reduce dengue disease severity. These
findings have important implications for future dengue vaccines.
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Introduction
Dengue virus infection can manifest as a clinically inapparent
infection, an undifferentiated febrile illness, classic dengue fever
(DF), or its more severe form, dengue hemorrhagic fever (DHF)
[1]. Inapparent dengue infection is defined as a dengue virus
infection that results in no clinical manifestations or an illness that
is mild and is not associated with a visit to a health care provider or
an absence from school or work due to illness. Inapparent dengue
infection because of its nature is not detected by surveillance
programs as most programs use visits to a health care provider or
hospitalization as an indicator of dengue illness. Thus, inapparent
dengue infection represents a burden of dengue infection that goes
undetected and hence ‘‘inapparent’’. The majority of dengue
infections in children is thought to be inapparent or present as an
undifferentiated febrile illnesses [2,3]. Determining the incidence
of inapparent dengue infection requires detailed prospective
cohort studies of populations in dengue endemic areas that can
detect dengue infection by paired dengue antibody serology
without an associated clinical illness during the time of
seroconversion. Few studies of this scope have been performed
and thus our knowledge on the full burden of dengue infection is
limited. In the first study of this type, a 2-year (1980–1981) school-
based study involving 1,757 children, ages 4–16 years, was
conducted in Bangkok, Thailand [4]. In this study a symptomatic-
to-inapparent (S:I) ratio of 1:8 was found. A 4-year study was
conducted in Managua, Nicaragua in approximately 3,800
schoolchildren, ages 2–9 years, during 2004–2008 [5]. The ratio
of S:I infections was 1:18 during the first year of the study and 1:3
during the fourth year of the study. A 3-year study, 2000 to 2002,
was conducted in 2,536 adults, ages 18–66 years, in West Java,
Indonesia [6]. The S:I ratio in this study was 1:3. Two studies were
performed in Kamphaeng Phet, Thailand, Kamphaeng Phet
Study I (KPSI) in 1998–2002 and KPSII in 2004–2008. The
overall S:I ratio in KPS I was 1:0.9 and in KPS II an S:I ratio of
1:3 [7,8]. We previously reported that there was variation in
the S:I ratio during KPS I that varied by school and year with
some schools experiencing an S:I ratio of 2:1 in one year
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year [9].
The pathogenesis of severe dengue disease, DHF, is thought to
be a consequence of a heightened immune response due to cross-
reactive T-cell responses and/or enhancing dengue antibody
during secondary dengue virus infection [10,11]. It is recognized
that dengue infection occurs across the clinical spectrum from
subclinical to dengue fever to severe shock and hemorrhage.
Understanding the pathogenesis and epidemiology of inapparent
dengue infections is important to understand the full burden of
dengue infection in a population, its role in underestimating the
degree of dengue transmission in a community, and the host and
viral factors responsible for influencing subclinical infections such
as sequence of serotype infection, heterotypic protective antibody,
and host genetic factors. Here we report the spatial and temporal
trends of the S:I ratio in dengue infection in a five-year prospective
cohort study conducted in Northern Thailand and the epidemi-
ologic factors associated with this variation.
Materials and Methods
This protocol was reviewed and approved by the Human Use
Review and Regulatory Agency of the Office of the Army Surgeon
General, the Institutional Review Board of the University of
Massachusetts Medical School, and the Thai Ethical Review
Board of the Ministry of Public Health, Thailand. All parents/
guardians of all children who participated in the study provided
informed consent.
The study methods have been previously described [7,12]. Briefly,
this study was conducted in the subdistrict Muang, Kamphaeng Phet
Province, Thailand during 1998 to 2002. At the time of the study,
subdistrict Muang had 92 public schools of which 12 primary schools
were selected to participate in this study based on reliable road access,
a desire to participate in the study, and a location within a 3-hour
driving radius from the field station laboratory. Children were
recruited during January 1998 from grades 1 through 5 and eligible to
remain in the study until graduation from 6
th grade. During each
subsequent year, new 1
st grade students were enrolled into the cohort
each January. Exclusion criteria included intent to move outside of the
study area during the 12 months following enrollment and a history of
thalassemia requiring blood transfusion. Baseline demographic
information, height and weight, and a blood sample were obtained
every January. Evaluations of the entire study population (height,
weight, blood sample for dengue serology) occurred three times during
the surveillance period (June 1st, August 15th and November 15
th)o f
each year. Active acute illness case surveillance of the study
participants occurred during the dengue season from June 1
st to
November 15
th. Students who were absent from school or visited the
school nurse with fever were evaluated the same day with a symptom
questionnaire and an oral temperature was obtained. Students with a
history of fever in the previous 7 days or an oral temperature $38uC
were evaluated with a physical exam and an acute illness blood sample
was obtained. A convalescent blood sample was obtained 14 days
later. Throughout June to November, including weekends and
holidays, research nurses tracked children who reported to the public
health clinic with an illness or were admitted to the hospital. Students
were evaluated using the same methods as above.
The laboratory assays used to detect acute dengue infection
were polymerase chain reaction [12], hemagglutination-inhibition
assays (HAI) [13], and anti-dengue Immunoglobulin (IgM/IgG
enzyme immunoassay (EIA) [14]. Dengue virus isolation in
Toxorhynchites splendens mosquitoes and enzyme immunoassay
were performed for identification of dengue virus serotypes
[15,16,17,18].
Clinical definitions of serologically or virologically confirmed
dengue virus infection were based on evidence of acute dengue
infection and a school-absence associated with fever. By EIA,
acute dengue virus infection was defined as a dengue virus-specific
IgM level of 40 units or more. Symptomatic dengue virus infection
was further classified as symptomatic non-hospitalized or symp-
tomatic hospitalized DF based on their admission into the hospital
as decided by the treating physician. Hospitalized symptomatic DF
was further defined as either DF or dengue hemorrhagic fever
(DHF) using World Health Organization criteria as previously
described [7].
Inapparent (subclinical) dengue virus infection was defined as a
four-fold rise in HAI antibody against any dengue virus serotype
between two sequential sera obtained during the surveillance
months (June, August or November) without a febrile illness
identified during active surveillance during the time period that
seroconversion occurred. For example in sera obtained from a
volunteer in June and August where an HAI antibody rise of four-
fold was detected to dengue virus with no period of school-absence
with fever in the same period was classified as an inapparent dengue
infection. Sera were tested concurrently for JEV specific HAI
antibody to exclude JEV infection and antibody cross-reactivity as a
cause for a fold-four rise in dengue antibody. HAI assays were
performed per referenced assays according to standard protocols
and interpreted using World Health Organization recognized
standards of HAI antibody in acute dengue virus infection [19].
Statistical analyses were performed using SPSS for Windows
version 12.0 (SPSS Inc.) and SAS analytic software, version 9.1
(Cary, NC: SAS Institute, Inc.). Only symptomatic and inapparent
dengue infections that were detected between June and November
each year were included in the analysis. This was done to avoid
misclassification of mild, non-hospitalized cases as inapparent
infections and altering the SI ratio as an artifact of surveillance. To
eliminate bias and due to the small number of primary dengue
infections noted in this population, only secondary dengue
infections were included for analysis.
Incidence rates were determined using the total study
population at the time of surveillance as the denominator.
Pearson’s chi-square and Spearman correlational analysis were
used to identify factors that were significantly associated with the
proportional occurrence of symptomatic infection by school and
by year. These proportions were then translated into SI ratios
Author Summary
Dengue viruses are a major cause of illness and
hospitalizations in tropical and subtropical regions of the
world. Severe dengue illness can cause prolonged
hospitalization and in some cases death in both children
and adults. The majority of dengue infections however are
inapparent, producing little clinical illness. Little is known
about the epidemiology or factors that determine the
incidence of inapparent infection. We describe in a study
of school children in Northern Thailand the changing
nature of symptomatic and inapparent dengue infection.
We demonstrate that the proportion of inapparent dengue
infection varies widely among schools during a year and
within schools during subsequent years. Important factors
that determine this variation are the amount of dengue
infection in a given and previous year. Our findings
provide an important insight in the virus-host interaction
that determines dengue severity, how severe a dengue
epidemic may be in a given year, and important clues on
how a dengue vaccine may be effective.
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(S:I) infections is equal to the probability of being symptomatic
over the probability of being inapparent for a given subgroup, i.e.
RatioSI=
PS
1{PS
{ (where PS= the proportion of infections that
were symptomatic). 95% confidence intervals were calculated for
the upper and lower limit of the probability of symptomatic
infection as PS+1:96|
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
PS|(1{PS)
n
r
and then translated to
ratios as above. Where the lower confidence interval for the
probability of symptomatic infection was negative or the upper
limit was greater than or equal to 1, these limits were reset to be 0
and 0.9999 to restrict the range to legitimate values for a ratio.
Logistic regression models were constructed to evaluate the
probability a child’s infection was inapparent, given school-level
characteristics of past (the year prior to a child’s infection) and
present (the year of the child’s infection) dengue epidemics at that
school. School-level characteristics that were considered included
the incidence of dengue infection, the proportion of infections that
were inapparent, the proportion of polymerase chain reaction
(PCR)-positive infections that were DENV-1 – DENV-4, and the
number of serotypes in circulation (as detected by PCR) at that
school. The incidence, proportion inapparent, and the proportions
of PCR-positive infections by serotype were categorized into
quartiles with the upper limit based upon the observed range for
each variable. Statistical analysis accounted for both clustering of
children by school and the longitudinal observation of children
who may have experienced multiple infections, using SAS PROC
GLIMMIX procedure and two levels of random effects. Multiple
individual models were constructed, controlling for each of the
exposure variables singly and incorporating the random effects.
Results
Population Demographics
The study population characteristics and incidence of acute
dengue infection was previously reported [7,12]. In January 1998,
Figure 1. Flow diagram of study population and data analysis. Flow diagram that demonstrates the population enrolled and disease
outcomes used in the analysis.
doi:10.1371/journal.pntd.0000975.g001
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remaining for the start of the surveillance. The overall flow of
study enrollment and case identification is demonstrated in the
flow diagram, figure 1. There was a gradual decline of the study
population at the start of active surveillance: 2,044 in 1998; 1,915
in 1999; 2,203 in 2000; 2,011 in 2001; and 1,759 in 2002. The
gradual decline of the study population over time is a reflection of
the changing demographics of the surveillance schools with smaller
1
st grade classes. The mean dropout rate over the study period was
5% primarily due to movement of families out of the surveillance
schools. No differences in sex distribution were noted from year to
year and between schools (data not shown).
1,024 dengue virus infections were detected in total over the 5
years of the study; 909 children experienced at least one dengue
infection during the study period and 115 experienced a second
infection. Restricting analyses to the 615 infections detected during
the active surveillance period (June 1– November 1), 66% (406) were
inapparent and 34% (209) were symptomatic. The median duration
of enrollment in the cohort study was two years (25
th percentile: 1
year and 75
th percentile: 4 years). 3331 children were enrolled for at
least one fullyear.27.3%ofchildren experienced at leastonedengue
infection during their period of enrollment. The vast majority of
acute infections were secondary by EIA (98%); only 4 infections
detected during the active surveillance period were primary.
The one-year incidence of total dengue infection and its
constituents, symptomatic and inapparent infection was: for 1998
16.2% (of which 68.1% of those infection detected during the
active surveillance period were inapparent); for 1999 13.6%
(66.7% inapparent); for 2000 5.2% (81.3% inapparent) for 2001
17.5 (58.0% inapparent); and for 2002 7.1% (66.2% inapparent).
There were no fatal cases of dengue. DHF represented 14.8% of
symptomatic infections, with the proportion varying yearly from a
minimum of 9.6% in 1998 to a maximum of18.2% in 2000. There
were no significant differences in the S:I ratio between males and
females (p=0.372 by Pearson chi-square).
Yearly Variation of the Symptomatic to Inapparent (S:I)
Ratio
Figure 2 demonstrates the annual variation of the S:I ratio for
the study population. The S:I ratio in this figure and all figures is
transformed into a single, scaled integer which represents the
number of symptomatic infections per 1 case of inapparent
infection. A value of 1 denotes equal numbers of symptomatic and
inapparent cases, an integer greater than 1 indicative of increasing
numbers of symptomatic infections, and an integer less than 1
indicative of increasing numbers of inapparent infections. As
shown, there is a significant annual variation of this ratio (p,.0001
by Pearson chi-square) with a relatively severe year noted in 2001.
S:I Ratio and Age
As demonstrated in figure 3, there was no correlation
between age and the S:I ratio (p..30 by Pearson chi square,
Figure 2. Symptomatic to inapparent ratio for all schools by year. Figure that demonstrates the S:I ratio for all schools in a given year.
doi:10.1371/journal.pntd.0000975.g002
Figure 3. Symptomatic to inapparent ratio by age. Figure that demonstrates the S:I ratio for each age.
doi:10.1371/journal.pntd.0000975.g003
Inapparent Dengue in Kamphaeng Phet, Thailand
www.plosntds.org 4 March 2011 | Volume 5 | Issue 3 | e975after categorizing into three-year intervals). Further, there was
no difference in the proportion of dengue infections that
were hospitalized by age (not shown). These findings are
contrary to the current belief that more severe dengue is
seen among older children and young adults. There were
however, four cases detected in the 15 and 16 years age group
over the 5 years of the study: all were symptomatic dengue
infections.
Figure 4. Symptomatic to Inapparent Ratio by Year and School. Figure that demonstrates the temporal and spatial variation of the S:I ratio.
Of note the error bars show 95% confidence intervals for the SI ratio. The upper limits that extend to 10 have actual upper limits of 999 (indicating
that the upper limit for the probability of symptomatic infection was greater than one) and were therefore adjusted to be 9.9 to make the upper limit
estimable. A value of zero indicates that all cases were inapparent in that school. Missing values indicates there were no acute dengue infections for
that school and year.
doi:10.1371/journal.pntd.0000975.g004
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www.plosntds.org 5 March 2011 | Volume 5 | Issue 3 | e975Figure 5. Symptomatic to Inapparent Ratio for Schools 1 to 12 by Year. Figure that demonstrates the individual experience of each school in
the yearly variation of the S:I ratio. Similar to figure 4 the error bars show 95% confidence intervals for the SI ratio. The upper limits that extend to 10
have actual upper limits of 999 (indicating that the upper limit for the probability of symptomatic infection was greater than one) and were therefore
adjusted to be 9.9 to make the upper limit estimable. A value of zero indicates that all cases were inapparent in that school. Missing values indicates
there were no acute dengue infections for that school and year.
doi:10.1371/journal.pntd.0000975.g005
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The spatial diversity of the S:I ratio was examined by schools and
by year. Children attending a given school tended to come from the
same village, therefore stratifying on school can provide insight into
smaller-scale spatial trends in disease and transmission. The total
distanceacrossthestudysite was30milesandtherefore schools(and
neighborhoods) tended to be separated by several miles.
As demonstrated in figure 4, there was considerable diversity in
the S:I ratio amongst schools. In 1998, school 7 had much more
severe disease with an S:I ratio of 5.0 as compared to other schools
during that year. In 1999, schools 6, 7 and 9 were more severe
than other schools; in 2000 school 3, 6, and 9 were more severe; in
2001 schools 2, 10 and 12 were more severe and in 2002, schools
4 and 10.
Variation of the S:I Ratio for Each School over Time
Temporal diversity of the S:I ratio was also examined for a given
school over time as demonstrated in figure 5. In general each school
had a unique experience with regard to changes in the S:I ratio over
time. For example, school 8 had relatively mild epidemics every
year from 1998–2002, but small-scale annual oscillations in severity
were observed. This was different than school 10, which had
relatively mild epidemic years from 1998 to 2000, followed by
relatively severe years in 2001 and 2002. School 7 had a clinically-
severe epidemic in 1998, a less a severe epidemic in 1999, and a
mild epidemic in 2001. Though each school had unique
characteristics regarding timing and the period of the changing
S:I ratios in their population, it is striking that in general, there were
cyclical shifts in the S:I ratio with 1 or 2 years of relative inapparent
dengue seasons were followed by more severe dengue years.
Significant Factors Associated with the Spatial and
Temporal Change in the S:I Ratio
All four dengue virus serotypes were detected over the study
period, though the number of serotypes in circulation varied each
year. In 2000, for example, only DENV-2 was detected in PCR+
symptomatic individuals while in 2002, all four DENV serotypes
were detected. One predominant dengue serotype was usually the
Table 1. Associations of the probability of subclinical dengue infection with epidemic characteristics.*
Present year’s epidemic characteristics
Regression coefficient (beta)
OR for a one unit increase in the
variable
(95% CI) {
Median
(Range) **
Dengue incidence 20.470 0.62
(0.53–0.74)
0.06
(0–0.41)
Proportion DENV-1 20.016 0.98
(0.90–1.07)
0
(0–1)
Proportion DENV-2 0.111 1.12
(0.98–1.28)
0.64
(0–1)
Proportion DENV-3 20.196 0.82
(0.68–0.99)
0
(0–1)
Proportion DENV-4 0.130 1.14
(0.39–3.32)
0
(0–1)
Number of DENV serotypes in circulation 20.247 0.78
(0.62–0.99)
1
(1–3)
Previous year’s epidemic characteristics
Regression coefficient (beta)
OR for a one unit increase in the
variable
(95% CI)
Median
(Range)
Previous year’s proportion inapparent 20.161 0.85
(0.70–1.03)
0.61
(0.20–1)
Previous year’s dengue incidence 0.293 1.34
(1.11–1.61)
0.09
(0–0.41)
Proportion DENV-1 0.049 1.05
(0.79–1.40)
0
(0–1)
Proportion DENV-2 20.153 0.86
(0.69–1.06)
0.64
(0–1)
Proportion DENV-3 0.275 1.32
(0.93–1.87)
0
(0–1)
Proportion DENV-4 --- --- ---
Number of DENV serotypes in circulation 0.028 1.03
(0.67–1.58)
1
(1–3)
*Epidemic characteristics at a given school, for a given epidemic year. Performed as individual logistic regression models with subclinical infection as the outcome
variable and each epidemic characteristic as a single exposure variable, and incorporating random effects for the individual and the individual’s school of attendance.
**. Each exposure variable was aggregated across each school and for each year. The median represents the midpoint of these aggregated values.
{A one-unit increase for proportions (incidence, proportion DENV-1 etc) was defined as a one-quartile increase in value. Quartiles were calculated based upon the range
of values (e.g., if incidence had a range of 0–40%, the upper limit for calculating quartiles of incidence was 40%, not 100%). A one-unit increase in the number of
serotypes in circulation compared 2 serotypes in circulation to 1 serotype in circulation, for example.
doi:10.1371/journal.pntd.0000975.t001
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previously described [12].
A higher incidence of infection at a given school, for a given
year, was associated with a lower proportion of inapparent
infections (i.e., a higher S:I ratio) during that epidemic season
(OR=0.62, 95% CI=0.53–0.74 for a 25% increase in incidence)
(Table 1). Similarly, having a higher number of serotypes in
circulation for a given year was associated with a decreased
likelihood of inapparent infections (OR=0.78, 95% CI: 0.62–
0.99). Serotype-specific effects were observed, with a higher
Figure 6. Proportion of infections that were inapparent by school and year. Figure that demonstrates the proportion of inapparent
infections during a given dengue virus transmission season.
doi:10.1371/journal.pntd.0000975.g006
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associated with a lower likelihood of inapparent infections
(OR=0.82, 95% CI: 0.68–0.99) and a higher proportion of
DENV-2 being weakly associated with a higher likelihood of
inapparent infections (OR=1.12, 95% CI: (0.98–1.28).
When considering the influence of a previous year’s epidemic
characteristics on the subsequent epidemic’s S:I ratio at a given
school, the prior incidence of infection had a strongly positive
association with the subsequent S:I ratio. That is, the higher the
incidence at a given school the year previous, the greater the
probability a child experienced an inapparent infection the
following year (OR=1.34 for a 25% increase in incidence,
p,0.01). A higher proportion of symptomatic infections at a given
school for the previous epidemic season was weakly associated with
an increased likelihood of inapparent infection the following year
(OR=0.85, 95% CI: 0.70–1.03).
In 1998, 2001, and 2002, there was a significant overall increase
in the proportion of inapparent dengue infections during the second
half of the active surveillance period for the entire study population
(Aug 16-Nov 1) compared to the first half (Jun 1-Aug 15) (p,0.01
for all, figure 6). For 1999 and 2000, the proportion inapparent
remained relatively constant between surveillance periods.
Discussion
Understanding the full burden of dengue infection and in
particular the burden of inapparent dengue infection has
important public health implications in understanding virus
transmission during an outbreak, the degree of under-reporting
during an outbreak year and our understanding on the
pathogenesis of dengue illness. Our study is unique from other
cohort studies on dengue infection for (1) its long-term follow-up of
a well-defined school cohort population; (2) its ability to distinguish
the entire spectrum of dengue virus infections and (3) determining
spatial and temporal patterns associated with dengue virus
transmission. In this report we examined the symptomatic to
inapparent ratio as an endpoint and as a correlate for disease
severity in a population spatially and over time.
Our results demonstrate that the S:I ratio, unlike in previous
reported studies, is not fixed and has wide variation in a
population in one specific geographic area and over time. Our
data demonstrates that dengue disease severity taken as a whole in
a population is an aggregate of multiple experiences of disease
severity in sub-populations, with some sub-populations experienc-
ing more severe illness and others less severe dengue infections. In
particular, we demonstrated that the previous year’s incidence of
dengue virus infection influences the subsequent year’s dengue
disease severity with higher incidence years followed by more
clinically-inapparent years. A similar trend has been observed at
the national level in Thailand- a cyclical nature in dengue
outbreaks and DHF with more severe years followed by milder
years [20].
Disease severity observed in our study could be related to a
number of factors such as the dengue serotype circulating in the
population, viral genetic factors associated with severe disease, and
the host’s preexisting immunity from a prior dengue virus infection
to another serotype leading to antibody enhancement and cross-
reactive memory T-cells or conversely cross-protective heterotypic
antibody. This would be consistent with previous observations on
the pathogenesis of severe dengue illness. Our findings did not
demonstrate an association between age and the S:I ratio in our
population. This might be due to the narrow age range of our
study population, ages 7 to 16 years, but more likely due to the
competing nature of other more important factors that influence
disease severity, such as the previous year’s severity. Our study did
not show significance for the proportion of a specific dengue virus
serotype and the number of circulating serotypes occurring during
an epidemic year or the previous year on the S:I ratio though
important factors as demonstrated in previous studies. This may
be due to the overwhelming influence of dengue infection in
general on disease severity rather than specific dengue serotypes.
Our finding that the greater the incidence of dengue infection of
the previous year’s epidemic, the milder the subsequent year’s
disease severity, raises the interesting possibility that herd
immunity is an important contributor to disease severity. This
could occur either by changing the subsequent year’s predominant
circulating dengue serotype(s) to a new circulating dengue virus
serotype because of protective antibody or by changing the host
immune response to experience milder illness. We have previously
demonstrated that cross-reactive heterotypic dengue neutralizing
antibody does not induce sterile immunity but may influence
disease severity on an individual level, at least for some viral
serotypes [21]. We believe that what we are observing in the
fluctuating nature of the S:I ratio in our population is the influence
of this heterotypic cross-reactive antibody at a population level.
Based on these findings we postulate that, as a dengue outbreak
with a high incidence and disease severity occurs in a given year in
a population, there is continued heterotypic herd antibody in a
population the following year that doesn’t provide protective
immunity from infection, but enough cross-protective activity to
lower disease severity. This could occur either at the individual or
population level. Thus the prior year’s S:I ratio and incidence has
an inverse relationship on the subsequent year’s S:I ratio.
Dengue is a global health concern with no effective vaccine to
prevent infection. Understanding the nature of inapparent dengue
infection has important public health implications in understand-
ing virus transmission, and determining disease burden during an
outbreak. Our findings increase the understanding of this disease
and the full burden of infection and point to a role of cross-reactive
heterotypic antibody in influencing disease severity the year after
an outbreak year in a population. Understanding the factors
associated with the development of inapparent dengue infection
will increase our understanding on the pathogenesis of this disease
and have important implications on how a tetravalent dengue
vaccine might influence disease severity in a population.
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